Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HengLi for Chronic Migraine
NCT02291380Phase 3Unknown
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd.
- Start
- Sep 2014
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of lanbotulinumtoxin-A in chronic migraine, sponsored by Lanzhou Institute of Biological Products Co., Ltd.. Status: unknown.
02
Drugs
lanbotulinumtoxin-A
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT02291380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291380.